Back to discover

Drug

Calcium Oxalate

Research stage

Emerging research

RxNorm1485048 ChEMBLCHEMBL3184709UNII2612HC57YE

1

Research papers

Latest activity

beta

Recent clinical, regulatory, research and industry developments relating to this drug.

A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease.

Research2023-07-19Nature communications

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name

Calcium Oxalate

RxNorm CUI

1485048

ChEMBL ID

CHEMBL3184709

UNII

2612HC57YE

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Most influential

A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease.

Nature communications · 2023 · 62 cites

Recent papers

A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease.

Nature communications · 2023 · 62 cites

Major research themes2

Kidney Calculi1Kidney Medulla1

Journals, researchers & institutions

Top journals

Nature communications1

Leading researchers

Barwinska D1
Bowen WS1
Canela VH1
Cheng YH1
Coe FL1
Eadon MT1
El-Achkar TM1
Ferkowicz M1

Leading institutions

free-text, unnormalised

Center for Diabetes and Metabolic Diseases1
Indiana University School of Medicine1
Indianapolis VA Medical Center1
San Diego Institute of Science1
University of Chicago1
University of Nebraska Medical Center1

References & data sources

RxNorm (U.S. National Library of Medicine) — drug identity
ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
Europe PMC — research literature